18
years in pharmaceutical intelligence and strategy
About DDI Signal
DDI Signal brings together drug development intelligence, strategic analysis and industry experience to help make complex pharmaceutical decisions clearer.
Why DDI Signal
Pharmaceutical organisations have access to more information than ever. The challenge is turning that information into a structured view of what matters, what is changing and what it means for the decision at hand.
DDI Signal was created around that principle: combine rigorous drug development intelligence with clear strategic interpretation, without adding unnecessary noise.
Founder
Life sciences strategy and intelligence professional with 18 years' experience across pharmaceutical R&D intelligence, competitive strategy and strategic decision support.
18
years in pharmaceutical intelligence and strategy
2007–2025
Pharmaprojects & Citeline
Top 10 Pharma
client and senior stakeholder experience
Prior to founding DDI Signal, Jonathan spent 18 years with Pharmaprojects and Citeline, most recently as Associate Director. His work included strategic consulting and competitive intelligence engagements for global biopharmaceutical organisations, including work with senior stakeholders across R&D, Medical Affairs and Commercial functions.
His experience spans pharmaceutical pipelines, clinical development programmes, competitive landscapes, portfolio and commercial decision support, data and intelligence strategy, and the translation of complex scientific and market information into clear strategic implications.
Scientific foundation
Jonathan holds an MPhil in Vascular Pharmacology and a BSc (Hons) in Pharmacology from the University of Portsmouth, providing a scientific foundation for work across pharmaceutical R&D, clinical development and emerging therapeutic landscapes.
Work with DDI Signal
If you are navigating a complex pharmaceutical landscape or strategic decision, we would be pleased to discuss where DDI Signal can help.